Abstract
In the present scenario, most of the developed and new discovered drugs are posing real challenge to the formulation scientists due to their poor aqueous solubility which in turn is responsible for poor bioavailability. One of the approach to overcome above problem is the packaging of the drug in to particulate carrier system. Among various carriers, lipid emerged as very attractive candidate because of its unique property of enhancing the bioavailability of poorly water soluble drugs. Solid lipid, one of the physical forms of lipid, is used to formulate nanoparticles, popularly known as Solid lipid nanoparticles (SLNs), as an alternative carrier system to emulsions, liposomes and polymeric micro- and nano-particles. SLNs combine advantages of the traditional systems but avoid some of their major disadvantages. This paper reviews numerous production techniques for SLNs along with their advantages and disadvantages. Special attention is paid to the characterization of the SLNs by using various analytical tools. It also emphasizes on physical state of lipid (supercooled melts, different lipid modifications).
Keywords: Homogenization, raman spectra, solid lipid nanoparticle, ultrasonication, lipophilic drug, aqueous solubility, lipid, emulsions, liposomes, polymeric micro- and nano-particles
Current Drug Discovery Technologies
Title: Preparation and Characterization of Solid Lipid Nanoparticles-A Review
Volume: 9 Issue: 1
Author(s): Rabinarayan Parhi and Padilama Suresh
Affiliation:
Keywords: Homogenization, raman spectra, solid lipid nanoparticle, ultrasonication, lipophilic drug, aqueous solubility, lipid, emulsions, liposomes, polymeric micro- and nano-particles
Abstract: In the present scenario, most of the developed and new discovered drugs are posing real challenge to the formulation scientists due to their poor aqueous solubility which in turn is responsible for poor bioavailability. One of the approach to overcome above problem is the packaging of the drug in to particulate carrier system. Among various carriers, lipid emerged as very attractive candidate because of its unique property of enhancing the bioavailability of poorly water soluble drugs. Solid lipid, one of the physical forms of lipid, is used to formulate nanoparticles, popularly known as Solid lipid nanoparticles (SLNs), as an alternative carrier system to emulsions, liposomes and polymeric micro- and nano-particles. SLNs combine advantages of the traditional systems but avoid some of their major disadvantages. This paper reviews numerous production techniques for SLNs along with their advantages and disadvantages. Special attention is paid to the characterization of the SLNs by using various analytical tools. It also emphasizes on physical state of lipid (supercooled melts, different lipid modifications).
Export Options
About this article
Cite this article as:
Parhi Rabinarayan and Suresh Padilama, Preparation and Characterization of Solid Lipid Nanoparticles-A Review, Current Drug Discovery Technologies 2012; 9 (1) . https://dx.doi.org/10.2174/157016312799304552
DOI https://dx.doi.org/10.2174/157016312799304552 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes
Current Enzyme Inhibition Germline Genetics of the p53 Pathway Affect Longevity in a Gender Specific Manner
Current Aging Science Modulation of Regulatory T Cells in Health and Disease: Role of Toll-Like Receptors
Inflammation & Allergy - Drug Targets (Discontinued) Cell Death in Mammalian Development
Current Pharmaceutical Design Novel Vaginal Drug Delivery Systems: A Review
Current Drug Therapy Blocking HIV-1 Vif Restores a Natural Mechanism of Intracellular Antiviral Defense
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Recent Advances in Active Hepatic Targeting Drug Delivery System
Current Drug Targets Multicomponent Determination of Drugs Using Flow-Injection Analysis
Current Pharmaceutical Analysis Development for Anticancer Therapy: Small-Molecule Inhibitors Targeting Protein Kinase B
Mini-Reviews in Medicinal Chemistry Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry Recent Advances of α-Glucosidase Inhibitors: A Comprehensive Review
Current Topics in Medicinal Chemistry Theranostic Potential of Targeted Nanoparticles for Brain Cancer
Mini-Reviews in Medicinal Chemistry Distribution and Biological Effects of Nanoparticles in the Reproductive System
Current Drug Metabolism Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis and Antiproliferative Activity of 3-aza Steroids as 5α-reductase Inhibitors
Letters in Drug Design & Discovery Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]
Current Pharmaceutical Design Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)
Current Pharmaceutical Design Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer
Current Clinical Pharmacology Importance of Amino Acids, Gln-119 and Tyr-376, in the S1 Pocket of Escherichia coli Peptidase N in Determining Substrate Specificity
Protein & Peptide Letters MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued)